Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Interim Management Statement

19 Nov 2010 07:00

RNS Number : 4647W
Huntsworth PLC
19 November 2010
 



 

 

 

 

19 November 2010

Huntsworth plc

("Huntsworth" or "the Group")

 

Interim Management Statement

 

Increased confidence of growth in 2011

Success in attracting global clients

Changes to Group Board

 

IMS Statement

Huntsworth plc, the global public relations and healthcare communications group, announces that it is trading in line with management profit and earnings expectations for 2010.

The Group has excellent margins both before and after central costs and a strong new business book running well into 2011 with about 65% of 2011 revenues already committed.

The Group has concentrated on using its new streamlined organisation to pitch for global and multi-office accounts in 2010. This strategy is bearing fruit and the Group has a very strong pipeline of international and global pitches, including our largest PR opportunity to date, which we expect to come on stream during the first quarter of 2011 and run for a number of years.

Contract negotiations for these larger international clients take several months and some revenue has moved from 2010 into next year. We therefore expect 2010 revenues to be below management's expectations but have renewed confidence that 2011 management revenue and profit expectations will be met.

 

The balance sheet remains robust with net debt comfortably within banking covenants. 

 

 

CITIGATE

Citigate, which is 15% of the Group, has won a number of new retained mandates including Hyder Consulting PLC and Oando PLC.

 

Recent transactions include United Business Media's $287m acquisition of Canon Communications LLC, Palamon Capital Partners LLP's €243m sale of Retail Decisions Ltd's Australian business and the IPO of Argos Resources Ltd.

 

 

GRAYLING

Grayling, which together with Dutko our public affairs business in Washington represents 49% of Group revenues, is seeing real momentum in pitching for, and winning, larger clients. The bulk of these wins will be worked on in 2011 and beyond.

 

Significant international wins include Volkswagen Middle East and Hilton Worldwide.

 

 

HUNTSWORTH HEALTH

Huntsworth Health, which is 29% of the Group, continues to gain in strength and reputation. We continued to build on our global structure which provided the rationale for Huntsworth Health to become a preferred provider in 14 different companies and the division is well placed to leverage this status in 2011. Digital revenues in particular continue to grow strongly.

 

 

RED

RED, which represents 7% of the Group, was hard hit by the cutback in public sector spending when the new coalition government was elected, but has recovered quickly replacing all public sector revenues with new commercial organisations including Barclaycard, Thistle Hotel Group plc, ACI Worldwide Ltd, Bravissimo Ltd and Napp Pharmaceutical Holdings.

 

Board Changes

Huntsworth also announces the following changes to the Board.

Colin Adams will join the Board as Group Finance Director. Colin has a strong background in the media sector, joining from Bloomsbury Publishing Plc where he has been Group Finance Director since 1994 and is a director on the main subsidiary boards within the group. In 2007 he was appointed to the Investment Committee of the Creative Capital Fund, an equity fund that provides seed capital investment to entrepreneurs and businesses in London's creative industries. It is intended he will join as soon as his contractual obligations allow which we anticipate will be in April 2011.

Tymon Broadhead, the current Group Finance Director and Company Secretary, will step down from the Board and leave the Company to pursue other career interests after an appropriate handover period during the first half of 2011.

 

Peter Chadlington, CEO of Huntsworth, said:

"We have made the very difficult transition from being a series of loosely affiliated companies into a streamlined, efficient international communications business. We have begun to demonstrate that we are able to compete for, and win, larger global mandates, served by many offices in multiple geographies.

"Colin is a media heavyweight with an outstanding track record in the sector. I'm confident he will play an important role in helping us take the group to the next stage of its development. Tymon's contribution to the development of Huntsworth has been exceptional and we wish him well for the future."

 

 

 

Enquiries:

 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Group Chief Executive

Sally Withey, Chief Operating Officer

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

George Cazenove

 

Additional information:

There is no other information required to be disclosed pursuant to LR9.6.13

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKFDBOBDDFDD
Date   Source Headline
6th Mar 20195:09 pmRNSHolding(s) in Company
6th Mar 20197:00 amRNSDirectorate Change
5th Mar 20197:00 amRNSPreliminary Results for year end 31 December 2018
4th Feb 20195:15 pmRNSHolding(s) in Company
28th Jan 20195:45 pmRNSHolding(s) in Company
21st Jan 20197:00 amRNSNotice of Results
11th Jan 20194:01 pmRNSHolding(s) in Company
7th Jan 20195:53 pmRNSStandard form for notification of major holdings
7th Jan 20195:14 pmRNSStandard form for notification of major holdings
7th Jan 20193:08 pmRNSStandard form for notification of major holdings
19th Dec 201810:00 amRNSDirectorate Change and Appointment of Chairman
17th Dec 201812:07 pmRNSSecond Price Monitoring Extn
17th Dec 201812:02 pmRNSPrice Monitoring Extension
13th Dec 20184:27 pmRNSHoldings in Company
12th Dec 20187:00 amRNSTrading Update
4th Dec 20186:04 pmRNSHolding(s) in Company
3rd Dec 20187:00 amRNSTotal Voting Rights and Capital
12th Nov 20181:25 pmRNSDirector/PDMR Shareholding
8th Nov 20182:23 pmRNSDirector Declaration
6th Nov 20183:23 pmRNSDirector/PDMR Shareholding
5th Nov 20187:00 amRNSAdditional Listing
1st Nov 20187:00 amRNSNotification of Total Voting Rights and Capital
29th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20184:56 pmRNSHolding in Company
9th Oct 20185:15 pmRNSDirector/PDMR Shareholding
8th Oct 20184:56 pmRNSTransfer of Treasury Shares
4th Oct 20184:31 pmRNSNotification of Major Holdings
4th Oct 20183:31 pmRNSScrip Dividend Alternative
4th Oct 20187:00 amRNSCompletion of Acquisition
3rd Oct 20184:57 pmRNSNotification of Major Holdings
3rd Oct 20184:41 pmRNSStandard form for notification of major holdings
3rd Oct 201810:43 amRNSNotification of Major Holdings
1st Oct 20185:22 pmRNSNotification of Major Holdings
28th Sep 201810:00 amRNSStandard form for notification of major holdings
28th Sep 20187:00 amRNSResults of placing
27th Sep 20184:56 pmRNSProposed acquisition of Navience Healthcare
26th Sep 20183:13 pmRNSStandard form for notification of major holdings
10th Aug 20185:01 pmRNSHolding in Company
10th Aug 20184:59 pmRNSHolding in Company
1st Aug 20187:00 amRNSTotal Voting Rights and Capital
24th Jul 20187:00 amRNSInterim results for the six months to 30 June 2018
17th Jul 20187:00 amRNSAcquisition of Giant Creative Strategy LLC
13th Jul 20184:11 pmRNSHolding in Company
12th Jul 201812:38 pmRNSHolding in Company
11th Jul 20183:00 pmRNSHolding in Company
5th Jul 20181:37 pmRNSHolding in Company
5th Jul 201810:07 amRNSDirector/PDMR Shareholding
4th Jul 20187:00 amRNSAdditional Listing
3rd Jul 201810:05 amRNSHolding in Company
3rd Jul 201810:04 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.